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ABSTRACT
mRNA 3′ end processing is an essential step in gene
expression. It is well established that canonical eu-
karyotic pre-mRNA 3′ processing is carried out within
a macromolecular machinery consisting of dozens
of trans-acting proteins. However, it is unknown
whether RNAs play any role in this process. Unex-
pectedly, we found that a subset of small nucleolar
RNAs (snoRNAs) are associated with the mammalian
mRNA 3′ processing complex. These snoRNAs pri-
marily interact with Fip1, a component of cleavage
and polyadenylation specificity factor (CPSF). We
have functionally characterized one of these snoR-
NAs and our results demonstrated that the U/A-rich
SNORD50A inhibits mRNA 3′ processing by block-
ing the Fip1-poly(A) site (PAS) interaction. Consis-
tently, SNORD50A depletion altered the Fip1–RNA
interaction landscape and changed the alternative
polyadenylation (APA) profiles and/or transcript lev-
els of a subset of genes. Taken together, our data
revealed a novel function for snoRNAs and provided
the first evidence that non-coding RNAs may play an
important role in regulating mRNA 3′ processing.
INTRODUCTION
Allmetazoan pre-mRNAs require extensive processing dur-
ing their maturation. One essential step is 3′ end processing
(1–4). Canonical mRNA 3′ processing involves an endonu-
cleolytic cleavage within the pre-mRNA sequences and the
addition of a poly(A) tail to the 3′ end of the transcript,
and both steps take place within a macromolecular ma-
chinery called mRNA 3′ processing complex (5–7). There
are ∼85 trans-acting proteins in the human mRNA 3′ pro-
cessing complex, including the poly(A) polymerase (PAP)
and four core multi-subunit complexes (CPSF, CstF, CF I
and CF II), as well as other peripheral factors that associate
with other biological processes (7). Despite much progress
in deciphering the protein–protein and RNA–protein in-
teraction within the mRNA 3′ processing complex (8–12),
it remains poorly understood how a specific poly(A) site
(PAS) is selected when multiple PASes are present in the
pre-mRNAs and how PAS selection can be regulated in a
tissue- or developmental stage-specific manner. These ques-
tions are important as alternative polyadenylation (APA)
is increasingly recognized as a critical mechanism for post-
transcriptional gene regulation (13–18), and APA regula-
tion impacts a variety of physiological processes including
stem cell differentiation and cancer development (19–20).
Although a number of protein factors have been shown to
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regulate APA, it remains completely unknown whether any
trans-acting RNAs may play a role in this process.
SnoRNAs are among the most abundant non-coding
RNAs (ncRNAs) in the nucleus, and they play an important
role in rRNA and snRNA modification, including uridine
isomerization and ribose methylation (21–22). Based on the
structural features, snoRNAs are classified into two fami-
lies, C/D-box and H/ACA-box snoRNAs. SnoRNAs bind
to target RNA sequences through base-pairing and recruit
partner proteins for modification. It is important to point
out that, for most snoRNAs, it has been difficult to experi-
mentally identify their target sequences, at least in part due
to the lack of complementarities of snoRNAs and their tar-
gets (23). Interestingly, there is accumulating evidence that
snoRNAs could be assembled into non-canonical snoRNP
particles and have a wide variety of functions, ranging from
RNA silencing, pre-mRNA splicing to chromatin decon-
densation (24–28). Some snoRNAs, such as SNORD50A, a
C/D-box snoRNA, has been previously implicated in a va-
riety of cancers (29–33). Therefore, it is important to delin-
eate snoRNA functions, both canonical and noncanonical.
In our attempt to systematically characterize the mam-
malian mRNA 3′ processing complex, we have unexpect-
edly found that a subset of snoRNAs physically associate
with the pre-mRNA 3′ processing complex. To elucidate the
potential function(s) of this association, we have focused
on SNORD50A and showed that this U/A-rich snoRNA
specifically binds to Fip1 and in turn blocks Fip1 interac-
tion with PAS sequences in vitro and in vivo. Consistently,
excess SNORD50A inhibits mRNA 3′ processing while its
depletion leads to an increase in mRNA 3′ processing ef-
ficiency and higher expression of many mRNAs. Our data
revealed a novel function for snoRNAs and provided the
first evidence that trans-acting RNAs can regulate mRNA
3′ processing.
MATERIALS AND METHODS
Cell culture and transfection
HeLa cells were cultured in DMEM with 10% FBS.
Modified ASOs (50 nM) targeting SNORD50A (ASO1:
mU∗mU∗mU∗mU∗mU∗T∗T∗T∗T∗C∗A∗A∗C∗A∗G∗m
A∗mA∗mG∗mU∗mU; ASO2: mC∗mU∗mC∗mA∗mG∗A
∗A∗G∗C∗C∗A∗G∗A∗T∗C∗mC∗mG∗mU∗mA∗mA; first
and last five nucleotides are 2′-O-methyl RNA, other 10
nucleotides are DNA; The backbone is linked by phos-
phorothioate bond) or siRNAs (50 nM) targeting Fip1
(CGAUGAAGAACGAUACAGATT) were transfected
with Lipofectamine RNAimax (Life Technology), and the
same with the corresponding nontarget controls. Lipo-
fectamine 2000 (Life Technology) was used to transfect
luciferase reporter plasmid pPASPORT and snoRNA over-
expression plasmid pCMV-globin. Cells were harvested
at the indicated time points for further analysis upon
transfection.
RNA-biotin based pull down assay
RNA substrates were made by in vitro transcription using
SP6 or T7 RNA polymerase and DNA templates (PCR
product or linearized Plasmid; two annealed DNA oligos
used for random RNA N75), and biotinylated at 3′ end
using a biotinylation Kit (Thermofisher). HeLa NEs were
made following the described protocol (34). Biotinylated
RNAs were first bound to the streptavidin beads, and then
incubated with HeLa NE in the polyadenylation conditions
[see (7) for details] for 20 min, after biotin–streptavidine
binding, washing, pull-down sample were heated (75◦ for
5 min) in 1× SSC buffer for elution, as suggested by the
manual of the Dynabeads M280. The eluted samples were
further subject to western blots and/or RNA purification
for RNA-seq/RT-qPCR.
Gel shift assays
Gel shift assays were performed by incubating P32 labeled
RNAs (detectable amount, ∼2 nM) with indicated amount
of GST-Fip1-RRM (or together with cold RNAs in com-
petition assay) in 15 l of binding buffer [10 mM HEPES
(pH 7.9), 50 mM NaCl, 0.5 mM MgCl2, 0.1 mM EDTA,
5% glycerol, 1 mM ATP, 10 mM creatine phosphate, 5 mM
-mercaptoethanol, 0.25 mM PMSF, 0.7 g of Escherichia
coli tRNA, and 1.4 g of BSA] at 30◦C for 10 min. Samples
were further loaded onto 5% nondenaturing PAGE gels.
The radioactivity signals were analyzed by PhosphorImager
(Typhoon FLA 7000).
Luciferase reporter assay
HeLa cells were harvested 24 h after transfection with
pPASPORT plasmids. Luciferase activity was measured us-
ing Promega Dual-Luciferase Reporter kit and Berthold
Sirius detection system.
In vitro mRNA 3′ processing assays
In vitro cleavage/polyadenylation and cleavage assays were
performed using P32-radiolabeled SVL PAS RNA se-
quences and HeLa NEs following standard protocol as de-
scribed elsewhere (8,11). Indicated amount of SNORA78
RNAs or SNORD50Awas added in the assay in Figure 2A.
Northern blot and RT-qPCR
Total RNAs were prepared using Trizol reagent (Life Tech-
nology). Ten microgram of total RNAs or other indicated
RNA samples were separated in 10% polyacrylamide–7
M urea gels and transfered onto positively charged nylon
membrane, using a semi-dry transfer apparatus (Bio-Rad).
Northern blot analysis of snoRNAs and U6 snRNA were
performed using 5′-radiolabeled DNA probes (see Supple-
mentary Table S5 for probe sequences) in ultrasensitive
hybridization Buffer (ThermoFisher). Real-time PCR was
performed in 96-well plates with LightCycler® 480 qPCR
system (Roche). Briefly, cDNAs were produced from tar-
get RNAs with superscript III (Life Technology) and quan-
tified by amplification using corresponding primers (see
Supplementary Table S5), qPCR data were analyzed by
Ct methods, and normalized by appropriate controls
(si-NC/NC-ASO/Gapdh/28S rRNA gene).
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Immnoprecipitation and western blots
All the antibodies for 3′ processing factors were fromBethyl
Laboratories, other antibodies were from Abcam or Santa
Cruz Biotechnology (Cat. number available on request).
Nuclear extract was diluted with equal volume of Buffer
D [20mM HEPES (pH 7.9); 100 mM NaCl; 1 mMMgCl2;
0.2 mMEDTA; 10mM -ME; 0.5 mMPMSF], and supple-
mented with 0.1% NP-40. IPs were performed using Dyn-
abeads with diluted NE and indicated antibodies. Immuno-
precipitated samples were further subject for western blots
or RNA extraction. For western blots, primary antibodies
are the same as the ones for IP. For secondary antibod-
ies, we used HRP-conjugated anti-mouse/rabbit (sigma)
or TrueBlot anti-mouse/rabbit (eBioscience). ECL western
blot system (ThermoFisher) was used to detect the signals.
RNA-seq
Strand-specific RNA-seq libraries were prepared following
the described protocol (35) with theRNA-biotin based pull-
down sample, and single-end squenceing (SE50) was carried
out in Illumina Genome Analyzer II platform. Raw reads
were trimmed by Trimmomatic (V0.32), and mapped to the
human genome (hg19), allowing up to two mismatches us-
ing OSA (Omicsoft Sequence Aligner, version 7.0.1.20). Ex-
pression level estimation was reported as TPM (transcripts
per million) value for each sample. Stringent cut-off param-
eters (average TPM > 200, fold change > 5) was applied to
select highly reliable changes.
PAS-seq
Oligo(dT) priming based PAS-seq libraries were prepared
following the 3PC protocol (36) with minor modification.
Briefly, 15 g total RNAs were fragmented, poly(A)+ tran-
scripts were converted into cDNA with a primer that con-
tains an oligo(dT) sequence, two primer binding sites for
nested PCR and two BamHI restriction enzyme sites. cD-
NAs were size-fractionated, purified, and further subject
to circularization and linearization. A limited number of
PCR cycles were used to amplify the linearized cDNAs.
Single-end sequencing (SE100) was carried out in Illumina
Genome Analyzer II platform. Raw reads were trimmed,
mapped to human genome (hg19), allowing up to two mis-
matches using Bowtie2 with the settings ‘bowtie2 -p 28 -
N 1 -k 1′. A poly(A) junction is where the 3′ end of the
read maps. Internal priming issue was addressed as de-
scribed previously (37). For the analysis shown in Fig-
ure 3, we first mapped and clustered the reads to En-
sembl genes (GRCh37.75). Next we used Fisher’s exact
test to compare the ratio of the read counts of one PAS
to the total read counts the same gene between two sam-
ples. PASes with an adjusted P-value <0.01 (adjusted by
Benjamini–Hochberg method) were considered as differ-
entially used. To create the scatter plot shown in Figure
3A, we selected two PASes with the smallest P-values for
each gene with multiple PASes. The PAS closer to the tran-
script start site is designated as the proximal PAS and
the other as distal. We then calculated the corresponding
proximal/distal ratio. PAS pairs with an adjusted P-value
<0.01 and |log2(control/SNORD50A KD-proximal/distal
ratio)| > 0.5 are highlighted (8). For gene expression anal-
ysis in Figure 3B, all the normalized PAS-seq reads (RPM)
for a gene were summed to stand for the expression level of
this gene, and DESeq2 package was used to analyzed the
gene expression change.
Fip1 iCLIP-seq
Fip1 iCLIP-seq was performed and analyzed essentially as
previously described (20).
RESULTS
A subset of snoRNAs are associated with the mRNA 3′ pro-
cessing complex
We have previously purified the human mRNA 3′ process-
ing complex and comprehensively characterized its pro-
tein composition (7). Next we wanted to explore the pos-
sibility that there may be RNAs associated with this com-
plex. To test this, we have purified the human mRNA
3′ processing complexes, extracted the associated RNAs,
and subjected them to high-throughput sequencing anal-
yses. Briefly, as illustrated in Figure 1A, we used SV40
late (SVL) PAS, a commonly used PAS RNA substrate for
in vitro mRNA 3′ processing assay (7,8,11,20,38). A mu-
tant RNA with a single point mutation (U to C) within
the poly(A) signal AAUAAA was used as negative control
as it does not allow the assembly of mRNA 3′ process-
ing complex. The RNA substrates were first biotinylated
at the 3′ end, and then bound to the streptavidin magnetic
beads. After incubationwithHeLa nuclear extract (NE) un-
der cleavage/polyadenylation conditions, the RNA–protein
complexes were purified by using biotin–streptavidin pull-
down. Western blot analyses revealed that all the known
3′ processing factors, includingWdr33, CPSF30, CPSF160,
CstF64, CstF64 (8–10,12,39–41), were specifically associ-
ated with the wild type PAS RNA, but not with the mu-
tant RNA (Figure 1B). These results are highly consis-
tent with previous studies (7), and suggest that our biotin–
streptavidin pull-down strategy is highly specific and suit-
able for identifying components of the mRNA 3′ processing
complex.
Next, we extracted RNAs from the purified human
mRNA 3′ processing complexes, prepared strand-specific
RNA-Seq libraries and subjected them to deep-sequencing
analyses using a previously described method (35). For
each library, we obtained around 1 million reads uniquely
mapped to the human genome. Using stringent cut-off pa-
rameters [average TPM >200, fold change (SVL/mutant)
> 5], we found 11 RNAs that are enriched in SVL RNA
pull-down sample compared to themutant RNApull-down
sample. (Supplementary Table S1). Remarkably, almost all
the enriched RNAs (10 out of 11) corresponded to snoR-
NAs. Among them, nine are C/D-box snoRNAs and 1
is H/ACA-box snoRNA. Similarly, 73% of the enriched
RNAs (64 out of 88) are snoRNAs if a less stringent cutoff
value (Average TPM>100, Fold change> 1.5) was applied.
These results indicated that specific snoRNAs were associ-
ated with mRNA 3′ processing. Importantly, although we
did not have replicates in the RNA-seq data, our follow-up
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Figure 1. Identification of trans-acting RNAs associated with mRNA 3′ processing. (A) Schematic representation of the SVL RNA substrates used in
the biotin–streptavidin pull-down assay. The AAUAAA hexamer in wild-type RNA substrate and AACAAA in mutant substrate (boxes) are shown.
The asterisk is used to highlight the single nucleotide change. (B) Western blot analysis of known core 3′ processing factors and snoRNP proteins in the
RNA-biotin based pull-down experiment. (C) The RNA-seq fold-change values for 4 snoRNAs that were enriched in wild-type SVL pull-down samples.
Northern blots were performed to confirm the enrichment (Left panel).
northern blot (Figure 1C) or RT-qPCR analysis (Supple-
mentary Figure S2A) has confirmed the fold changes for
all of the nine randomly selected snoRNAs, suggesting that
our sequencing analyses were highly reliable.
snoRNAs are known to assemble into RNPs with sev-
eral specific protein partners (22).Given our surprising find-
ing that specific snoRNAs were enriched in the pull-down
sample, we next asked if the canonical snoRNP particles
were captured under our purification conditions. To this
end, we have performed Western blotting analyses of our
purified mRNA 3′ processing complexes for known core
snoRNP proteins such as dyskerin, NOP58 and fibrillarin
(22,42,43). Consistent with previous proteomic analyses re-
sults (7), we failed to detect these proteins in the pull-down
samples (Figure 1B), indicating that the snoRNAs associ-
ated with mRNA 3′ processing complexes were not assem-
bled into the canonical snoRNPs.
SNORD50A inhibits SVL PAS 3′ processing in vitro and in
vivo
We next asked whether mRNA 3′ processing complex-
associated snoRNAs play a role in mRNA 3′ processing.
To this end, we have focused on SNORD50A, which is the
most enriched snoRNA in the SVL mRNA 3′ processing
complex (Figure 1C). Interestingly, SNORD50A has been
reported to be associated with cancers (29–33).
We first tested the effect of SNORD50A on mRNA 3′
processing in vitro. To this end, we carried out in vitro
cleavage/polyadenylation assay in the presence of increas-
ing amount of SNORD50A. SNORA78 was used as a neg-
ative control as it does not associate withmRNA 3′ process-
ing complex (Supplementary Table S1). As shown in Figure
2A and Supplementary Figure S1A, SNORD50A signif-
icantly inhibited SVL cleavage/polyadenylation efficiency
in a dose-dependent manner while SNORA78 had no ef-
fect, suggesting that SNORD50A can specifically suppress
mRNA 3′ processing at SVL PAS in vitro.
To test the role of SNORD50A in vivo, we over-expressed
SNORD50A and several control snoRNAs (SNORA16A,
SNORD20 and SNORA78) that are not associated with
mRNA 3′ processing complex in HeLa cells using a pre-
viously reported vector system (44,45; Supplementary Fig-
ure S1B). Briefly, in this expression system, snoRNA in-
sert was processed from the second intron of human -
globin gene, which had been placed downstream of the cy-
tomegalovirus (CMV) promoter. Our RT-qPCR analyses
showed that transfection of pCMV-globin-snoRNA expres-
sion construct led to a ∼50-fold increase of correspond-
ing snoRNA compared to the transfection of a control
vector (Supplementary Figure S1B). Additionally, we have
also validated the overexpression of SNORD50A through
Northern blot analysis (Supplementary Figure S1B). To as-
sess the effect of snoRNA overexpression onmRNA 3′ pro-
cessing efficiency in vivo, we took advantage of a previously
described bicistronic luciferase reporter construct, pPAS-
PORT ((8,9,20); Supplementary Figure S1C). Briefly, in this
assay system, efficient mRNA 3′ processing at the tested
PAS leads to high expression of Renilla luciferase gene and
low expression of Firefly luciferase gene, while poor mRNA
3′ processing results in the opposite mode of gene expres-
sion. Therefore the Renilla/Firefly ratio provides a quan-
titatively measurement of the cleavage/polyadenylation ef-
ficiency at the tested PAS. Our results showed that overex-
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Figure 2. Functional characterization of SNORD50A in SVL PAS 3′ processing. (A) In vitro cleavage /polyadenylation (left) and cleavage (right) assays
using SVL PAS RNA substrate and nuclear extract fromHeLa cells in the presence of SNORA78 RNA oligo (0, 5,10, 15 M) or SNORD50A (0, 5, 10, 15
M). pre-mRNA, polyadenylated mRNA, 5′ cleavage product are indicated. (B) Luciferase reporter assays to determine the impact of individual snoRNA
overexpression on SVL PAS 3′ processing. pCMV-globin control vector and pCMV-globin-snoRNA expression construct were transfected into HeLa cells,
after 2 days, SVL PAS activities were determined by transfecting pPASPORT-SVL plasmid construct into HeLa cells and measuring the Rluc/Fluc ratio 1
day after the transfection. The ratios were normalized by the value of SVL PAS activity in HeLa cells transfected with pCMV-globin control vector, and
plotted as mean±S.E.M. (n = 3). Student’s t-test was used to determine the significance of the change. n.s.: not significant; **P < 0.01. (C) Northern blot
analysis of SNORD50A expression in control HeLa cells and HeLa cells transfected with negative control (NC) ASO, 2 ASOs (ASO-1, ASO-2) targeting
SNORD50A. Total RNAs were harvested 2 days after transfection. U6 snRNA expression serves as loading control. (D) Luciferase reporter assays to
determine the impact of SNORD50A depletion on SVL PAS 3′ processing. Control and SNORD50A ASOs were transfected into HeLa cells, after 2 days,
SVL PAS activities were determined by transfecting pPASPORT-SVL plasmid construct into HeLa cells and measuring the Rluc/Fluc ratio 1 day after the
transfection. The ratios were normalized by the value of SVL PAS activity in control HeLa cells and plotted as mean ± S.E.M. (n = 3). Student’s t-test
was used to determine the significance of the change. **P <0 .01.
pression of SNORD50A led to significant inhibition of SVL
3′ processing efficiency compared to that of other control
snoRNAs (Figure 2B), suggesting that SNORD50A can
specifically suppress mRNA 3′ processing at SVL PAS in
vivo.
To further study the function of SNORD50A in vivo, we
next depleted SNORD50A in HeLa cells using antisense
oligonucleotides (ASO), which has been well established
as a specific and efficient tool for depleting nuclear ncR-
NAs, including snoRNAs (46,47). Consistent with previ-
ous results, SNORD50A was specifically depleted by 90%
upon ASO transfection (46) (Figure 2C). Using this sys-
tem, we first assessed the effect of SNORD50A depletion
onmRNA3′ processing efficiency using the aforementioned
reporter. Our results showed that the mRNA 3′ processing
efficiency for the SVL PAS was moderately increased upon
SNORD50A knockdown (Figure 2D). snoRNAs are in-
volved in rRNAmodification and snoRNAdepletion could
affect translation. To rule out any indirect effect in our re-
porter assay, we also quantified Renilla and Firefly mRNA
levels in our reporter assays by RT-qPCR. Consistently,
the ratio of Renilla/Firefly mRNA is significantly higher
in SNORD50A knockdown sample (Supplementary Figure
S1C). Therefore, our in vivo and in vitro analyses provided
consistent and strong evidence that SNORD50A negatively
regulates mRNA 3′ processing at the SVL PAS.
SNORD50A modulates APA and expression level of endoge-
nous mRNAs
A number of core mRNA 3′ processing factors or their
associated proteins have been shown to regulate APA
and/or transcript abundance in vivo and their impacts
are gene-specific (8,9,11,20,48,49). Next, we asked whether
SNORD50A can impact global APA and gene expression
profiles. To this end, 3PC (3′ PolyA site mapping using
cDNA circularization), a previously characterized PAS-
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Figure 3. Effect of SNORD50A depletion on the 3′ processing and expression level of endogenous poly(A)+ transcripts. (A) PAS-seq analysis of APA in
HeLa cells 2 days after they were transfected with NC ASO or SNORD50A ASO (ASO-1 and ASO-2 as a group), Log2(proximal/distal ratio) are plotted
for HeLa cells transfected with NC ASO (y-axis) and SNORD50A KD ASO (x-axis). Statistically significant changes are highlighted in blue (proximal
to distal shift) and red (distal to proximal shift). The numbers of APA changes are shown in the column graph. (B) Volcano plot showing the expression
level change of poly(A)+ mRNA in HeLa cells 2 days after they were transfected with NC ASO or SNORD50A ASO (ASO-1 and ASO-2 as a group).
Highly reliable changes (P<0.05, fold change>4) were colored with red (up-regulated in SNORD50A KD cells in comparison to NC KD cells) or blue
(down-regulated in SNORD50A KD sample in comparison to NC KD cells), green dots shows the changes either not statistically significant (P>0.05) or
less reliable (fold change<4). (C) IGV tracks showing the PAS-seq results forHccs, Egr1 genes in HeLa cells with NC (top) or SNORD50A KD (bottom).
(D) RT-qPCR analysis monitoring the relative expression levels of 3 mature and precursor transcripts in HeLa cells 2 days after they were transfected with
NC ASO or SNORD50A ASO. Fold changes are relative to Gapdh and normalized to NC ASO control, plotted as mean±S.E.M. (n = 3). Student’s t-test
was used to determine the significance of the change. n.s.: not significant; ** P<0.01. (E) Luciferase reporter assays are similar to Figure 2D except that the
targets are 5 endogenous mRNAs PASes instead of SVL PAS. Student’s t-test was used to determine the significance of the PAS activity change, **P<0.01.
seq (PolyA Site Sequencing) method capable of quantify-
ing polyA+ transcripts and gene expression at transcrip-
tomic level (36), was carried out in negative control (NC)
and SNORD50A knockdown HeLa cells (see Methods for
details). Our PAS-seq analyses detected significant APA
changes in 157 genes between control and SNORD50A-
depleted cells. Among them, 65 genes showed a shift toward
distal PASes while 92 genes showed a shift toward proximal
PASes (Figure 3A; Supplementary Table S3). In addition
to APA changes, the mRNA levels of 1290 genes were up-
regulated and 878 genes down-regulated upon SNORD50A
depletion by more than 2-fold, including 477 genes up-
regulated and 60 genes down-regulated by >4-fold (Figure
3B; Supplementary Table S4). Figure 3C shows represen-
tative examples of the APA (top panel) and gene expres-
sion changes (bottom panel). Gene ontology analysis of the
highly up-regulated genes [log2(fold change) > 2; RPM >
100] revealed a significant enrichment of genes that func-
tion in cell stress/proliferation/apoptosis (Supplementary
Figure S3A), while the same analysis returned no enriched
functional groups in down-regulated genes. These results
suggest that SNORD50A regulates the expression of a sub-
set of genes and its effect is largely negative.
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mRNA 3′ processing complex-associated snoRNAs directly
bind to Fip1
To begin to characterize the mechanisms for snoRNA-
mediated regulation of mRNA 3′ processing, we set out
to identify the direct binding partner(s) of these snoRNAs
within the mRNA 3′ processing complex. To this end, we
immunoprecipitated (IP)many known 3′ processing factors,
extracted their associated RNAs, and performed RT-qPCR
analysis using primers specific for the four most highly en-
riched snoRNAs found in the mRNA 3′ processing com-
plex. Interestingly, we found that all four snoRNAs were
most enriched in Fip1 IP sample (Supplementary Figure
S2B). In addition to Fip1, which is a subunit of the CPSF
complex, snoRNAs were also associated with some other
CPSF subunits with moderate efficiency (Supplementary
Figure S2B). To further test the association between CPSF
and snoRNAs, we have performed pull-down assays with
biotinylated-snoRNAs and HeLa NE. Our results showed
that CPSF subunits were greatly enriched in biotinylated-
snoRNAs pull-down sample compared to the biotinylated
random RNAs and SNORA78, a snoRNA that is not as-
sociated with mRNA 3′ processing complex based on our
analyses (Figure 4A; Supplementary Table S1). These data
suggest that a subset of snoRNAs binds to mRNA 3′ pro-
cessing complex at least in part through association with the
CPSF complex.
To determine which CPSF subunit(s) directly bind to
these four snoRNAs in vivo, we performed CLIP (UV cross-
linking and immunoprecipitation) using antibodies against
five CPSF subunits, extracted RNAs, and carried out RT-
qPCR to detect specific target RNAs. It has been well estab-
lished that CLIP detects direct protein–RNA interactions
in vivo (50). Additionally, to further ensure that we were
detecting specific protein–RNA interactions and not RNA
interactions of other associated proteins, we denatured the
cell lysates by heating it at 75◦C for 5 min in the presence of
SDS before immunoprecipitating protein–RNA complexes
(Supplementary Figure S2C). Under such denaturing con-
ditions, all protein–protein interactions were disrupted as
evidenced by the absence of other CPSF subunits in Fip1
IP samples (Supplementary Figure S2C). Under this con-
dition, we found that four snoRNAs were significantly en-
riched in the Fip1 IP sample compared to the IP samples
of other CPSF subunits (Figure 4B). Consistently, exami-
nation of previous published CLIP-seq (UV cross-linking
and immunoprecipitation followed by high-throughput se-
quencing) data of 3′ processing factors in HEK293 cells
showed that CPSF subunits bind to all four snoRNAs and
that Fip1 has the highest CLIP-seq signals for SNORD50A
and snoRD22 (51) (Supplementary Table S2). In keeping
with our earlier results, we did not detect any of the canon-
ical snoRNP proteins in Fip1 IP sample (Supplementary
Figure S2D). Taken together, these results strongly suggest
that a subset of snoRNAs associate with mRNA 3′ process-
ing, at least in part, by directly binding to Fip1.
SNORD50A blocks Fip1–PAS interaction
We next wished to test whether and how SNORD50A–Fip1
interaction impacts mRNA 3′ processing activities. We first
asked whether SNORD50A modulates Fip1 interactions
with RNAs or other proteins within the mRNA 3′ process-
ing complex. To test this, we incubated SVL pre-mRNA
substrate with control and SNORD50A-depletedHeLaNE
under cleaveage/polyadenylation conditions, immunopre-
cipitated Fip1, and extracted RNAs or proteins from IP
samples. Our western blot analyses of the IP samples de-
tected similar amounts of CPSF160, CPSF73 and CPSF30,
suggesting SNORD50A depletion had little effect on the
interactions between Fip1 and other 3′ processing factors
(Figure 4C, top panel, western blot). In contrast, as shown
in Figure 4C (bottompanel), we found thatmore SVLRNA
substrates were recovered by Fip1 IP in SNORD50A de-
pleted samples, suggesting that SNORD50A inhibits Fip1
interaction with the SVL PAS RNA.
How does SNORD50A inhibit the interaction between
Fip1 and SVL pre-mRNA? We envisioned two scenar-
ios: first, SNORD50A binds to SVL PAS through base-
pairing and the resultant RNA duplex inhibits Fip1 bind-
ing to SVL. Second, SNORD50A may interact with Fip1,
thereby blocking Fip1 interaction with SVL PAS. To test
the first hypothesis, radiolabeled SVL PAS RNA sequence
were biotinylated at 3′ end, and incubated with radiola-
beled SNORD50A under cleavage/polyadenylation condi-
tions. biotin–streptavidin pull-down assay showed that SVL
PAS did not interact with SNORD50A in vitro (Figure 4D,
lane 3). In contrast, the anti-sense RNA (of the same length
as SNORD50A) to a portion of SVL PAS was able to bind
to SVL PAS, while the sense sequence of the same region
serves as a negative control (Figure 4D, lanes 1 and 2). These
data suggest that SNORD50A does not hybridize to SVL
PAS RNA.
We next tested the second hypothesis. Previous reports
have suggested that Fip1 binds toU-rich sequence upstream
of AAUAAA (20,38,51). A sequence comparison showed
that the SNORD50A sequence is similar to a portion of
the SVL PAS sequence upstream of the AAUAAA hex-
amer (Figure 3B), raising the possibility that SNORD50A
might compete with SVL PAS RNA for binding to Fip1.
Previous studies have shown that Fip1 binds to RNA via
its arginine-rich C terminal region (Fip1-C) (38). To test
this idea, we performed gel shift assay using recombinant
Fip1-C (GST-Fip1-C) and SVL PAS RNA. Indeed, GST-
Fip1-C binds to both SNORD50A and SVL PAS upstream
element (USE). We next performed a competition assays
by incubating GST-Fip1-C, radio-labeled SVL PAS RNA,
and increasing amounts of unlabeled SNORD50A RNA
as competitors. Our results showed that SNORD50A, but
not SNORA78, could outcompete SVLUSE for binding to
Fip1-C (Figure 4E, left and right picture).
Our above results suggest that SNORD50A directly
binds to Fip1 and serves as a competitive inhibitor for SVL
PAS 3′ processing. Intriguingly, SNORD50A was identified
within purified mRNA 3′ processing complex. How does
this inhibitory snoRNA incorporated into the mRNA 3′
processing? Considering our Fip1 IP and RT-qPCR data,
we hypothesize that SNORD50A binds to Fip1, which is
assembled into mRNA 3′ processing complex through its
interactions with other CPSF subunits. To test this, we per-
formed the aforementioned RNA-biotin pull-down experi-
ments using SVL PAS and nuclear extracts fromHeLa cells
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Figure 4. Mechanism study of SNORD50A-mediated SVL PAS 3′ processing regulation. (A) snoRNAs interact with CPSF in an in vitro binding assay.
Control RNAs and four snoRNAs were biotinylated at 3′ end and incubated with HeLa NE in polyadenylation conditions, after binding, elution, biotin–
streptavidin pull-down sample were subject to western blot analysis using antibodies against indicated CPSF subunits. (B) RT-qPCR analysis of the
relative abundance of four snoRNAs in immunoprecipitated samples, IP was performed using 50 l HeLa nuclear extract and 2 g indicated antibodies.
10% input HeLa NE was used as normalization control. The IP step was performed following CLIP method (50) with modification (see result section for
details). (C) Autoradiography of the P32 labeled SVL pre-mRNA (bottom) and Western blot analysis of CPSF subunits (top) from immunoprecipitation
using Fip1 antibodies with control HeLa cell nuclear extracts (control) or nuclear extracts from NC ASO treated HeLa cells (NC), or nuclear extracts
from SNORD50A ASO treated HeLa cells (ASO1, ASO2). P32-labeled SVL pre-mRNA were incubated with nuclear extracts under polyadenylation
conditions for 20 minutes before immunoprecipitation. (D) RNA–biotin based pull-down assay showing SNORD50A did not bind to SVL RNA under
polyadenylation conditions. Pairwise sequence alignment between SNORD50A and SVL PAS RNA sequences using CLUSTALW program (top). Same
nucleotides were colored with red. AAUAAA hexamer and cleavage site within SVL PAS are shown in box and arrow respectively. SVL USE sequence
marked with black line was used for gel shift, competition binding assay and pull-down assay. P32 radiolabeled SVL PAS was biotinylated at 3′ end, and
incubated with same P32 radiolabeled SNORD50A or control RNA sequences (SVL USE serves as negative control, while its reverse complementary
sequence serves as positive control) under buffer conditions compatible for polyadenylation. Pull-down samples were washed, eluted, and resolved by
denaturing PAGE. (E) Gel mobility shift assays using GST-Fip1-RRM (25, 50 M) and the P32 labeled RNA sequences (left), GST (50 M) or no protein
was used as control. For the RNA competition binding assay (right), SNORA78 RNA oligos (0, 5, 10, 15 M) or SNORD50A (0, 5, 10, 15 M) was
present in the gel mobility shift assay using GST-Fip1-RRM (10 M) and P32-labeled SVLUSE RNA sequence. As negative control (middle), SNORA78
were not able to form stable complex with GST-Fip1-RRM.
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Figure 5. Mechanism study of SNORD50A assembly into CPSF and its
effect on the interaction of CPSF with SVL PAS. (A) Western blot analysis
of Fip1 expression in HeLa cells treated with negative control siRNA and
siRNA targeting Fip1. (B) Northern blot analysis of SNORD50A (top)
and western blot analysis of CPSF subunits (bottom) in SVL RNA–biotin
based pull-down samples (left panel) and CPSF73 immunoprecipitated
samples (right panel). Nuclear extracts from HeLa cells treated with NC
siRNA or Fip1 siRNAwere used in the pull-down assays. (C) Autoradiog-
raphy of the P32 labeled SVLpre-mRNA (top) andwestern blot analysis of
WDR33/CPSF30 from immunoprecipitation using WDR33/CPSF30 an-
tibodies with nuclear extracts fromNCASO/siRNA treatedHeLa cells, or
nuclear extracts from SNORD50A ASO/Fip1 siRNA treated HeLa cells.
P32 labeled SVL pre-mRNA were incubated with nuclear extracts under
polyadenylation conditions for 20 min before immunoprecipitation.
transfected with control siRNAor Fip1 siRNA (20) (Figure
5A). Northern blot analysis showed that a lower amount of
SNORD50A was assembled on SVL PAS when nuclear ex-
tracts from HeLa cells treated with Fip1 siRNA was used
(Figure 5B, left picture, top). Consistently, CPSF73 IP ex-
periments using HeLa NEs showed that less amount of
SNORD50Awas present withinCPSF uponFip1 depletion
(Figure 5B, right picture, top). Interestingly, Fip1 KD did
not affect the integrity of the CPSF complex or the recruit-
ment of CPSF to SVL PAS (Figure 5B, left and right pic-
tures, bottom). These results suggest that Fip1 indeed me-
diates the recruitment of SNORD50A to CPSF and in turn
the mRNA 3′ processing complex.
We next investigated whether SNORD50A also blocks
the interaction of other CPSF subunits with SVL PAS. To
address this, we performed similar experiment as described
in Figure 4C. Briefly, radiolabeled SVL PAS RNA was in-
cubated with HeLa NE and RNA-IP was carried out us-
ing antibodies against WDR33 or CPSF30, we focused on
these two proteins as recent studies demonstrated that they
directly bind to AAUAAAwithin mammalian PAS (10,12).
Our results showed that knockdown of either SNORD50A
or Fip1 had no significant effect on the association between
WDR33 and CPSF30 with SVL PAS (Figure 5C). Together,
these data suggest that SNORD50A specifically blocks Fip1
interaction with SVL PAS.
SNORD50A regulates 3′ processing of endogenous mRNAs
at least in part via modulation of the interaction of Fip1 with
PASes
To determine whether and how snoRNAs affect endoge-
nous mRNA 3′ processing, we next wished to select sev-
eral direct target sites for SNORD50A from the 477 up-
regulated genes in SNORD50A KD cells and characterize
themechanism for SNORD50A-mediated regulation of cel-
lular PASes. Previous studies have indicated that, for genes
containing more than one PAS, the PAS selection could be
affected by a variety of factors, including the relative intrin-
sic strength of the different PASes, the length between the
alternative PASes, and splicing (14,18,20,52). Therefore, to
minimize the number of factors that may complicate our
mechanistic study, we focused on 106 genes that only have
a single PAS (Supplementary Table S4).
Next we selected several mRNA targets among the top
candidates on the list for further verification. Consistent
with PAS-seq data, elevated expression of the three se-
lected mRNAs upon SNORD50A depletion were con-
firmed by RT-qPCR analysis (Figure 3D, right panel). The
increased mRNA levels of these genes could be due to
lower mRNA turnover rate and/or higher transcriptional
activity. To distinguish between these possibilities, we first
employed actinomycin D chase technique to measure the
half-lives of the three mRNAs after SNORD50A depletion.
No significant differences were observed between control
and SNORD50A knockdown cells (Supplementary Figure
S3B), indicating that SNORD50A did not affect the turn-
over rates of these mRNAs. To check the effect of snoR-
NAs on transcriptional activity, we monitored the nascent
transcript levels by measuring the levels of unspliced tran-
scripts from these genes. Our results showed they were not
significantly altered (Figure 3D, left panel), indicating that
the synthesis of nascent transcripts was not affected. There-
fore, we hypothesized that the up-regulation of the three
mRNAs could be due to more efficient mRNA 3′ process-
ing after SNORD50A depletion. To test this idea, we mea-
sured the mRNA 3′ processing efficiency at the PASes of
the snoRNA target genes using the bicistronic luciferase re-
porter as described in Figure 2B. Indeed, higher mRNA
3′ processing activity was observed for all three PASes in
SNORD50A knockdown cells (Figure 3E). In contrast,
PAS activity of beta-actin and podxl2 genes were not af-
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fected by SNORD50A depletion. These data strongly sug-
gest that SNORD50A inhibits the 3′ processing of specific
PASes in vivo.
We next wished to further characterize the effect of
SNORD50A on these endogenous PASes. First, we syn-
thesized these PASes (–100 to +100 nt relative to the
cleavage site) in vitro and performed biotin–RNA IP us-
ing HeLa NE as described earlier. As expected, these
biotinylated-RNAs efficiently pulled down CPSF factors
and SNORD50A (Figure 6A). These results indicated that
SNORD50A was physically associated with the mRNA
3′ processing complexes assembled on these endogenous
PAS sequences. Second, we performed pair-wise sequence
alignment between SNORD50A and these PAS regions.
Interestingly, SNORD50A is highly U/A-rich and shows
high sequence similarity to a region near the poly(A) sig-
nal ‘A(U/A)UAAA’ (Supplementary Figure S3C). Third,
SNORD50A and the homologous regions within these
PASes could compete for binding to Fip1, as demon-
strated by the competitive gel mobility shift assay (Sup-
plementary Figure S3C). Finally, at the genome-wide level,
SNORD50A shows significantly higher sequence homology
with PAS sequences of up-regulated genes than with control
mRNA sequences (Supplementary Figure S3D and E).
The above results, together with the analysis on SVL
PAS RNA substrate, prompted us to investigate whether
SNORD50A systematically affects Fip1–mRNA interac-
tion at PAS region in vivo. To address this, we performed
Fip1 iCLIP-seq in control and SNORD50AKDHeLa cells.
Consistent with previous reports (20,38), our results showed
that Fip1 preferentially binds to RNA sequences upstream
of A(A/U)UAAA hexamer and cleavage/polyadenylation
sites in control HeLa cells. In SNORD50A KD cells, how-
ever, Fip1RNAbinding sites weremore broadly distributed
and the median position was shifted 15 nucleotides relative
toA(A/U)UAAA (Figure 6B; Supplementary Figure S4A).
Moreover, significantly higher Fip1 iCLIP-seq signals were
observed surrounding PAS sequences upon SNORD50A
KD (Figure 6C), as seen in Ptch2 mRNA (Figure 6D).
These results are consistent with our in vitro analysis on
SVL substrate and supports a model wherein SNORD50A
blocks the interaction of Fip1 with PASes and suppresses
mRNA 3′ processing and the expression level of target mR-
NAs.
To understand how higher Fip1-PAS interaction con-
tributes to higher gene expression levels for a subset of
genes, we first divided expressed genes into three groups
based on their fold change values between SNORD50A
knockdown and control cells, namely up-regulated, un-
changed, and down-regulated genes. Interestingly, after
SNORD50A knockdown, significant higher Fip1 iCLIP-
seq signals were detected surrounding PAS regions for all
three groups (Supplementary Figure S4B). In search for
sequence features that may explain this specific mode of
gene regulation, we examined the PAS sequences of the 100
most up-regulated genes. Our results showed these PASes
are more U-rich around the cleavage/polyadenylation site
(–100 to 100 nt) in comparison to the PASes of other groups,
with the most significant U-rich observed at region (–100 to
–30 nt) (Figure 6E; Supplementary Figure S4C). As Fip1
is known to predominantly interacts with U rich upstream
element of PASes (20,38), this result is consistent with our
model that SNORD50A regulatesmRNA3′ processing and
expression of mRNAs through modulating Fip1–RNA in-
teractions.
DISCUSSION
In this study, we have provided, to the best of our knowl-
edge, the first experimental evidence that snoRNAs are in-
volved in regulatingmRNA3′ processing. Through detailed
functional studies of a specific snoRNA, SNORD50A, we
showed that theU/A-rich SNORD50A could compete with
specific PAS cis-element for binding to Fip1, thus serv-
ing as a negative regulator in target PAS 3′ processing. As
such SNORD50A controls APA and expression level of tar-
get mRNAs in vivo. A schematic model of SNORD50A-
mediated regulation of mRNA 3′ processing is presented in
Figure 7. These results not only provided new insights into
the mechanism of mRNA 3′ processing, but also extended
our understanding of the functions of snoRNAs.
Several early studies provided evidence that the mRNA
3′ processing complex might contain an snRNA (53,54).
For example, micrococcal nuclease treatment of nuclear ex-
tract abolishes mRNA 3′ processing activity, indicating that
one or more RNAs are required for mRNA 3′ process-
ing. A later study, however, showed that adding purified
E. coli RNAs restored mRNA 3′ processing to micrococ-
cal nuclease-treated nuclear extract (55). These studies indi-
cate that some RNA component may play a role in mRNA
3′ processing, but no specific RNA seems to be required
for mRNA 3′ processing. In this report, we showed that
several snoRNAs were associated with Fip1 in the mRNA
3′ processing complex. Our functional characterization of
SNORD50A, including the analysis from snoRNA over-
expression and luciferase reporter assays (Figure 2), sug-
gest that CPSF-interacting snoRNAs predominantly serve
as negative regulators in a sequence-dependent manner.
Therefore, we conclude that snoRNAs are not essential for
mRNA 3′ processing, but play a regulatory role.
It has been increasingly recognized that both canonical
and non-canonical snoRNPs exist in cells (22,28,56–60),
and thus the same snoRNAs could be assembled into dif-
ferent protein complexes for distinct functions. Indeed, ac-
cumulating evidence suggests that snoRNAs have a wide
variety of noncanonical functions, ranging from RNA si-
lencing, pre-mRNA splicing to chromatin decondensation
(24–28). However, the dual functionality of snoRNAs may
complicate functional studies. For example, we showed that
SNORD50A depletion usingASO causedAPA andmRNA
level changes in many target genes. Given the function
of snoRNAs in rRNA modification, it is conceivable that
some observed effect in SNORD50A-depleted cells could
be due to ribosome-associated translation defects. How-
ever, our data strongly argue against this possibility. First,
SNORD50A is physically associated with specific mRNA
3′ processing factors, and is assembled into mRNA 3′ pro-
cessing complexes of specific PASes (Figures 4B and 6A).
Second, the association between snoRNAs and mRNA
3′ processing complexes is highly specific. For example,
our results showed that SNORD50A is associated with
the mRNA 3′ processing complex assembled on the SVL
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Figure 6. Mechanism study of SNORD50A-mediated endogenous mRNA 3′ processing regulation. (A) Endogenous mRNA PAS sequences interact with
CPSF in an in vitro binding assay. Control RNAs (SVL-M PAS: negative control; SVL PAS: positive control; random N75: random technique control,
Podxl2 PAS: non-target PAS control) and three mRNA PAS RNA sequences were biotinylated at 3′ end and incubated with HeLa NE in polyadenylation
conditions, after binding, elution, biotin–streptavidin pull-down sample were subject to western blot analysis using antibodies against indicated CPSF
subunits, and RNA purification for SNORD50A semi-quantification by RT-qPCR. (B) Distribution of Fip1 binding sites (red line: based on Fip1 iCLIP-
seq data in control KD HeLa cells; green line: based on Fip1 iCLIP-seq data in SNORD50A KD HeLa cells) and cleavage sites (based on PAS-seq data)
relative to closest upstream A(A/U)UAAA element. Position 0 stands for the 3′ end of A(A/U)UAAA. (C) Paired Student’s t-test was used to compare
the relative Fip1 binding frequency across PAS region (–150 nt to 150 nt region relative to cleavage site) for all the 3106 mRNAs (Fip1 iCLIP+ at PAS
region) in HeLa cells upon SNORD50A KD. y-axis shows the number of total Fip1 iCLIP reads (normalized by RPM) across the PAS region. Bar graphs
are plotted as mean ± SEM (n = 3106). **P < 0.01. (D) PAS-seq and Fip1 iCLIP-seq tracks on the Ptch2 gene. Normalized RPM values are shown for
each sample (NC and SNORD50A KD HeLa cells) in the track. (E) Genes were divided into three groups based on log2(FC) value, namely up-regulated
genes, down-regulated genes, unchanged genes (shown in red, green and blue, respectively). Distribution of percentages of U nucleotide sequence across
PAS site region (–100 nt to 100 nt relative to cleavage/polyadenylation site) for the 3 groups of genes were plotted.
PAS. Interestingly, however, SNORD50B, a homolog of
SNORD50A with 68.8% sequence identity, was not de-
tected (Supplementary Table S1). Third, RT-qPCRanalyses
of our bicistronic reporter showed that SNORD50A over-
expression or depletion led to altered mRNA 3′ processing
efficiency at the tested PAS. Together, these data strongly
suggest that snoRNAs directly regulate mRNA 3′ process-
ing.
Further studies are needed to fully understand the scope,
mechanisms, and functional significance of snoRNA or
other non-coding RNA-mediated regulation of mRNA 3′
processing. First, it will be important to identify other
snoRNAs that also regulate mRNA 3′ processing. In this
study, we identified a subset of snoRNAs in the mRNA 3′
processing complex assembled on the SVL PAS. It is pos-
sible that distinct snoRNAs or other types of non-coding
RNAs may associate with the mRNA 3′ processing com-
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Figure 7. A schematic model of SNORD50A-mediated regulation of mRNA 3′ processing. In normal HeLa cells, SNORD50A is assembled into CPSF via
Fip1, and attentuates the interaction of Fip1 with the U rich USE region of PASes, the suboptimal interactions between Fip1 and PASes ensure controlled
mRNA 3′ processing activity and proper gene expressions. However, in SNORD50A KD HeLa cells, Fip1 in general tends to bind more frequently to
PASes, and thus increased the 3′ processing and gene expression of target mRNAs containing more U rich sequences at the USE of PAS.
plexes and/or regulate mRNA 3′ processing. Indeed, Y3**
ncRNA has recently been reported to promote the histone
pre-mRNAs 3′ processing by enhancing the recruitment of
the CPSF to histone pre-mRNA (61). Second, it will be im-
portant to understand how snoRNAs can regulate specific
mRNA targets by binding to general mRNA 3′ processing
factors. Although themechanisms are not fully understood,
this could be due to the fact that general mRNA 3′ process-
ing factors themselves regulate the mRNA processing and
APA of specific mRNAs (8,9,11,20,48,49). Finally, it will
be important to understand the functional significance of
snoRNA-mediated regulation of mRNA 3′ processing. For
example, SNORD50A/B gene locus is lost in 10–40% of 12
common cancers, and the mechanism may involves the di-
rect association of SNORD50A/BwithK-Ras (33). Our re-
sults showed that SNORD50A-regulated targets are highly
enriched for genes that function in proliferation and apop-
tosis (Supplementary Figure S3A), raising the possibility
that snoRNA-mediatedmRNA3′ processingmay contribu-
tion to cancer development. A key challenge for future stud-
ies is the potential functional redundancy of snoRNAs. For
example, SNORD50A knockout mice only displayedminor
defects (32), raising the possibility that other snoRNAsmay
at least partially compensate for its loss in its canonical and
noncanonical functions.
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